Results 101 to 110 of about 40,760 (162)

Use of Rifampicin as a Cytochrome Inducer in Acute Tacrolimus Poisoning. [PDF]

Open Respir Arch
Margallo Iribarnegaray J, Alonso Moralejo R, Quezada Loaiza CA, Ortega Ruiz L, Ruiz Rodriguez M, De Pablo Gafas A.   +5 more
europepmc   +1 more source

Molecular basis for the activation of the bitter taste receptor TAS2R14 by Ritonavir. [PDF]

PLoS One
Wen J, Ma X, Zhou X, Kissell RC, Lu Y, Kim Y, Lee YS, Lee A, Chen S, Xu K, Plant LD, Cui M.   +11 more
europepmc   +1 more source

HIV-1 drug resistance and genetic clustering among ART-treated individuals with virologic failure in Aksu, China. [PDF]

Front Microbiol
Dai Z, Li H, Xu M, Feng J, Sun L, Lu D, Bi Y.   +6 more
europepmc   +1 more source

Managing Drug-Drug Interactions Involving the Non-Prescription Opioid Loperamide Through Physiologically Based Pharmacokinetic Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Zhou Z, Ainslie GR, Li M, Dinh J, Zamek-Gliszczynski MJ, Zhao P, Paine MF.   +6 more
europepmc   +1 more source

Reassessing the Conduct of Patch Clamp Cardiac Ion Channel Assays to Improve Nonclinical Data Translation to Clinical ECG Changes and Proarrythmia Risk. [PDF]

Clin Transl Sci
Alvarez Baron C, Zhao J, Guo D, Mistry S, De Palma R, Ismaiel OA, Wu WW.   +6 more
europepmc   +1 more source

COVID-19 treatment of hospital patients worldwide at the onset of the pandemic in 2020: a systematic review. [PDF]

BMC Infect Dis
Bosquet A, Affo C, Happe F, Helfer H, Versini E, Mahé I.   +5 more
europepmc   +1 more source

Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial. [PDF]

Trials
Blomberg B, Myklebust NN, Oppegaard O, Tøndel C, Cox RJ, Iversen A, Lehmann ME, Sandvig A, Dahl TB, Valderhaug VD, Szodoray P, Wilhelmsen M, Kirsebom BE, Glambek M, Kaarbøe O, Aukrust P, Lie RT, Langeland N.   +17 more
europepmc   +1 more source

Pharmacist follow-up of patients prescribed nirmatrelvir/ritonavir: a single-center retrospective analysis. [PDF]

J Pharm Health Care Sci
Shigeno A, Ohashi Y, Masui R, Kiryu A, Nagashima K, Ohashi H, Seto K, Masuda J, Teruya K, Ujiie M, Ohmagari N, Nishimura T.   +11 more
europepmc   +1 more source

HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial. [PDF]

J Antimicrob Chemother
Schönenberger CM, Haenggi K, Ringera IK, Luoga E, Bresser M, Mothobi B, Mokhele K, Sando D, Molatelle M, Thahane L, Mnzava D, Ndege R, Hlasoa MM, Kayembe BP, Muhairwe J, Glass TR, Klimkait T, Weisser M, Labhardt ND, Tschumi N, Brown JA.   +20 more
europepmc   +1 more source

Rapid establishment of public sector COVID-19 test-and-treatment programmes across seven low- and middle-income countries: implementation strategies and program monitoring results. [PDF]

BMJ Glob Health
Boeke CE, Hamza N, Agwuocha C, Amako O, Detleuxay K, Gao M, Griffith BC, Gumulira Y, Urli Hodges E, Joseph J, Lufesi N, Macharia E, Mbewe N, McCarthy E, Mintah FO, Mukiibi M, Mulenga M, Ngwije A, Ofori-Boadu L, Okoli IU, Phongphila S, Ramers C, Regan S, Twinomujuni E, Rwagasore E, Tebor J, Udayakumar K, COVID-19 Treatment QuickStart Consortium.   +27 more
europepmc   +1 more source